Moderna’s COVID-19 Vaccine Triggers Immune Response

July 20, 2020

Moderna’s COVID-19 Vaccine Triggers Immune Response

Moderna has released initial results from its first in human trial of a coronavirus vaccine, which prompted an immune response in all 45 volunteers to receive it. The company has plans to begin a larger phase III clinical trial, which will test 30,000 people, with half receiving a placebo, beginning July 27. This trial is expected to be completed in October. Yourway has the capacity to provide clinical supplies, storage, and transportation for large-scale trials around the world.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat

Hello! How can I help you?